Molecular Pathologist

City of Hope•Duarte, CA

2d•$310,000 - $480,000•Onsite

About The Position

City of Hope Medical Group is seeking a full-time academic Molecular Genomic Pathologist to join their growing team in Duarte, CA. This position is at the Assistant/Associate level within the Department of Pathology. The successful candidate will serve as a faculty clinician in the Division of Molecular Pathology and Therapy Biomarkers, with primary responsibilities in the Clinical Molecular Diagnostics Laboratory (CMDL). The role involves collaborating with a diverse team to advance genomic diagnostics, translational research, education, and patient-centered care. The CMDL is a high-volume, state-of-the-art laboratory performing over 39,000 molecular tests annually, focusing on next-generation sequencing (NGS) and other advanced molecular methodologies. The position plays an integral role in expanding molecular diagnostic testing, developing innovative genomic technologies, and implementing precision oncology initiatives. Responsibilities include interpreting molecular and genomics results, participating in assay development, validation, quality management, molecular tumor boards, and translational research. Faculty are expected to contribute to scholarly productivity through publications, grant development, and national professional activities. The role offers opportunities for clinical service, teaching, mentorship, and research. Faculty will represent Clinical Laboratories on various committees and may provide coverage for other pathology services, including limited sign-out in surgical pathology or hematopathology. Collaboration will extend across multiple City of Hope locations.

Requirements

Medical Doctor (MD) or Doctor of Osteopathic Medicine (DO) degree.
Board eligible or board certified in Molecular Genetic Pathology (MGP) or Molecular Genomic Pathology.
Board certified in Anatomic Pathology and/or Clinical Pathology (AP/CP preferred) through the American Board of Pathology.
Eligible for unrestricted medical licensure in the State of California.
Expertise in next-generation sequencing (NGS), molecular oncology, somatic tumor testing, and genomic interpretation for solid tumors and hematologic malignancies.
Knowledge of assay development, validation, implementation, quality assurance/quality control, personnel training, and regulatory compliance for both FDA-approved and laboratory-developed tests (LDTs).
Strong understanding of CAP, CLIA, New York State (if applicable), and other accreditation and regulatory requirements governing high-complexity molecular testing.
Commitment to maintaining the highest standards of patient care, quality, safety, compliance, and operational excellence.
Ability to collaborate effectively with pathologists, clinicians, laboratory scientists, bioinformaticians, researchers, and operational leaders across the enterprise.
Excellent interpersonal, communication, leadership, and negotiation skills.
Ability to think strategically and innovate while advancing institutional initiatives in genomics, cytogenomics, clinical operations, education, and research.
Demonstrated commitment to education and mentorship of residents, fellows, medical students, and laboratory trainees.
Participation in scholarly activities, including publications, presentations, and collaborative translational research.

Nice To Haves

A minimum of two (2) years of experience working in or directing a clinical Molecular Genomic Pathology laboratory is preferred.
Exceptionally qualified candidates with fellowship training and demonstrated academic potential will also be considered.
Board certified in Molecular Genetic Pathology (MGP) by the American Board of Pathology.
Additional fellowship training and/or board certification in Hematopathology, Cytogenetics, Clinical Informatics, or related disciplines is desirable.
More than two (2) years of faculty experience in an academic molecular pathology program.
Experience with translational research, Institutional Review Board (IRB) protocols, grant-supported research, and advanced molecular genomics methodologies, including whole-genome sequencing, optical genome mapping, CytoScan, OncoScan, and other genome-wide array technologies.
Demonstrated ability to develop strategic plans for program growth, test utilization, laboratory integration, and expansion of molecular diagnostic services.
Record of scholarly activity, including peer-reviewed publications, translational research, grant funding, or clinical trial support.
Experience mentoring residents, fellows, graduate students, or junior faculty.

Responsibilities

Interpret and report molecular and genomics results in correlation with hematopathology assay results, surgical pathology relevant biomarker analysis, and HLA results in a bone marrow transplant setting.
Play an integral role in the continued expansion of molecular diagnostic testing across the City of Hope enterprise.
Develop and implement innovative genomic technologies, companion diagnostics, and precision oncology initiatives.
Actively participate in assay development, validation, laboratory-developed testing, quality management initiatives, molecular tumor boards, and proficiency testing.
Engage in translational research and clinical trials.
Contribute to scholarly productivity through publications, grant development, collaborative research, and national professional activities.
Represent the Clinical Laboratories on test utilization, departmental quality initiatives, Molecular Genomic Pathology diagnostic strategy, and laboratory information systems committees.
Provide coverage and on-call support for other pathology services.
Provide a limited effort allocation for diagnostic sign-out in surgical pathology or hematopathology, based on candidate's training, board certification, and departmental needs.
Collaborate with laboratory directors and clinical leaders across the City of Hope enterprise.
Promote excellence in clinical laboratory operations, research, education, and patient-centered care.
Foster a culture of innovation, collaboration, and professional development.
Provide clinical consultation and multidisciplinary support for precision medicine initiatives and molecular tumor boards.
Ensure knowledge of assay development, validation, implementation, quality assurance/quality control, personnel training, and regulatory compliance for both FDA-approved and laboratory-developed tests (LDTs).
Maintain the highest standards of patient care, quality, safety, compliance, and operational excellence.
Collaborate effectively with pathologists, clinicians, laboratory scientists, bioinformaticians, researchers, and operational leaders across the enterprise.
Think strategically and innovate while advancing institutional initiatives in genomics, cytogenomics, clinical operations, education, and research.
Demonstrate commitment to education and mentorship of residents, fellows, medical students, and laboratory trainees.
Participate in scholarly activities, including publications, presentations, and collaborative translational research.